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ABSTRACT 25 
Chitosan/collagen (Chit/Col) blends have demonstrated great potential for use in tissue 26 
engineering (TE) applications. However, there exists a lack of detailed study on the 27 
influence of important design parameters (i.e, component ratio or crosslinking methods) 28 
on the essential properties of the scaffolds (morphology, mechanical stiffness, swelling, 29 
degradation and cytotoxicity). This work entailed a systematic study of these essential 30 
properties of three Chit/Col compositions, covering a wide range of component ratios 31 
and using different crosslinking methods. Our results showed the possibility of tailoring 32 
these properties by changing component ratios, since different interactions occurred 33 
between Chit/Col: samples with Chit-enriched compositions showed a hydrogen-34 
bonding type complex (HC), whereas a self-crosslinking phenomenon was induced in 35 
Col-enriched scaffolds. Additionally, material and biological properties of the resultant 36 
matrices were further adjusted and tuned by changing crosslinking conditions. In such 37 
way, we obtained a wide range of scaffolds whose properties were tailored to meet 38 
specific needs of TE applications. 39 
 40 
 41 
 42 
 43 
 44 
 45 
 46 
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1. INTRODUCTION 50 
 Regenerative medicine is an emerging field that aims to improve or repair the 51 
performance of a damaged tissue or an organ. Cells are used in combination with 3D 52 
scaffolds, based on biocompatible biomaterials, for developing suitable tissue 53 
engineering (TE) constructs (Langer, 2000; Langer & Vacanti, 1993). The main 54 
function of TE scaffolds, i.e. cell supports, is to mimic the function of extracellular 55 
matrix (ECM) which not only provides an appropriate mechanical environment for 56 
cells, but also supplies signals that direct cell attachment, proliferation, differentiation 57 
and metabolism. The choice of biomaterials and the selection of experimental 58 
conditions for design of these scaffolds are essential parameters in assuring the 59 
appropriate setting for cells to grow and proliferate within these 3D matrices (O’Brien, 60 
2011; Ou & Hosseinkhani, 2014).  61 
 Proteins and polysaccharides are considered promising natural molecules for the 62 
design of 3D scaffolds with the required characteristics for TE applications (Chen et al., 63 
2012; Fischbach, Kong, Hsiong, Evangelista, Yuen & Mooney, 2009; Gurski, Jha, 64 
Zhang, Jia & Farach-Carson, 2009). This work has been focused on the use of collagen 65 
(the most abundant protein in the extracellular matrix, ECM) and chitosan (a natural 66 
polysaccharide structurally similar to glycosaminoglycans) as main components for the 67 
development of 3D porous scaffolds for potential applications in a variety of tissue 68 
engineering procedures.  69 
 It is well documented that both collagen (Col) and chitosan (Chit) have great 70 
potential in the design of a variety of bioactive materials for different biomedical 71 
purposes (Croisier & Jérôme, 2013; Szot, Buchanan, Freeman & Rylander, 2011).  72 
Collagen possesses excellent biocompatibility and biodegradability and comprises the 73 
repetitive array of receptor-recognition motifs essential for cell interaction via specific 74 
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collagen-binding β1 integrins, such as GFOGER motif (G: glycine; F: phenylalanine; O: 75 
hydroxylproline; E: glutamate and R: arginine) (Knight, Morton, Peachey, Tuckwell, 76 
Farndale & Barnes, 2000; Yannas, Tzeranis, Harley & So, 2010). Consequently, 77 
collagen-based scaffolds should not only mechanically support the native tissue during 78 
repair, but also play an important role in providing essential signals to influence cell 79 
activity (Yannas, Tzeranis, Harley & So, 2010).  80 
 Chitosan, a biocompatible and biodegradable polymer with structural 81 
characteristics similar to the glycosaminoglycans, exhibits various interesting biological 82 
properties, such as biocompatibility, good interaction with cell membranes and lack of 83 
immunogenicity (Croisier & Jérôme, 2013; Kievit et al., 2010). It has been reported that 84 
this natural polysaccharide can stimulate the activity of growth factors, contribute to the 85 
maintenance of cell phenotypes, especially in terms of its morphology, and play an 86 
important role as a structural component of scaffolds for soft and hard tissue 87 
regeneration (Croisier & Jérôme, 2013). The chitosan-based 3D matrices have showed 88 
both in vitro cytocompatibility and in vivo biocompatibility (Guzman et al., 2014). One 89 
of the interesting features of chitosan is its cationic nature in acidic solutions due to its 90 
protonated primary amine groups. The cationic charges allow chitosan to form water-91 
insoluble ionic complexes with a variety of polyanionic substances (Croisier & Jérôme, 92 
2013), for example, with negatively charged collagen. It should be mentioned that in the 93 
natural ECM, proteoglycans and glycosaminoglycans have important roles in 94 
intertwining with the fibrous structure of collagen to obtain mechanical stability and 95 
compressive strength (Fernandes, Resende, Tavares, Soares, CastroI & GranjeiroI, 96 
2011). Therefore, it seems interesting to develop mixed collagen-chitosan scaffolds in 97 
order to create more suitable biomimetic microenvironments for cells compared to those 98 
provided by pure Col or Chit matrices.  99 
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 It is well known that various chemical crosslinkers are frequently introduced in 100 
the production process (Davidenko, Campbell, Thian, Watson & Cameron, 2010; 101 
Denkbas & Ottenbrite, 2006) to enhance the structural stability of natural polymer-102 
based scaffolds. 1-Ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride 103 
(EDAC) in the presence of N-hydroxysuccinimide (NHS), and sodium tripolyphosphate 104 
(TPP) are two of the most commonly used chemical agents which work in a different 105 
manner and on different types of molecules. EDAC activates carboxylic acid groups on 106 
the collagen-type molecules forming ‘‘zero length” crosslinks with free primary amine 107 
groups of polypeptide chains. TPP is widely used to improve the stability of chitosan-108 
based materials and acts through ionic interactions with chitosan amine groups. Both 109 
cross-linkers are considered to be non-toxic and biocompatible, features which favour 110 
their use in the enhancement of scaffold stability. Therefore, essential material and 111 
biological properties of the resultant matrices obtained with different component 112 
fraction might be further adjusted and tuned by use of these chemical treatments (alone 113 
or in combination). 114 
 Due to evident potential of collagen-chitosan blends, a variety of these kinds of 115 
composite biomaterials, including porous matrices, have been developed for different 116 
biomedical purposes (Ti et al., 2015; Zeng et al., 2014). Cytocompatibility and some 117 
physical properties of blended scaffolds were determined and compared to those of pure 118 
Chit or Col samples (Fernandes, Resende, Tavares, Soares, CastroI & GranjeiroI, 2011). 119 
There is, however,  a lack  of detailed and systematic study on the influence of 120 
important design parameters, such as component ratio (over a wide range of values) and 121 
the use of the different chemical treatments (crosslinking methods), on the  essential 122 
structural, physico-chemical, mechanical and biological properties of the scaffolds.  123 
  124 
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 Therefore, the main objective of this study was to determine the effect of 125 
changing composition and crosslinking methods on both the essential material 126 
properties and the biological suitability of scaffolds obtained from different collagen-127 
chitosan mixtures. Three Chit/Col compositions, namely Chit/Col=80/20, 50/50 and 128 
20/80 (w/w%) were selected to cover a wide range of component ratios. This choice 129 
was based on the fact that depending upon the component fraction in the mixture and 130 
experimental conditions, different kind of interaction could take place between these 131 
two polymers (Taravel & Domard, 1996). It was expected, therefore, that both polymers 132 
would not only contribute to the final composite properties with their own 133 
characteristics, according to their content in the blend, but also would interact with each 134 
other, and form different kinds of complexes which would subsequently influence the 135 
mechanics and dissolution kinetics of the resultant materials.  136 
 Our expectations were based on reports (Taravel & Domard, 1993, 1995, 1996) 137 
showing that principally two kinds of interactions can arise between these two polymers 138 
when they are in contact with water. The first is electrostatic in nature and corresponds 139 
to the formation of a polyanion/polycation (PA/PC) complex between the two types of 140 
polyelectrolytes. Theoretically, the best conditions for this interaction should be 141 
achieved under the stoichiometric ratio of 18.5% (w/w) between chitosan and collagen. 142 
In this work 20Chit/80Col mixture was selected to reproduce this condition. (Taravel & 143 
Domard, 1993, 1995, 1996). In addition to this, a hydrogen-bonding type complex (HC) 144 
may also be formed, especially in the presence of a large excess of chitosan. 145 
80Chit/20Col composition was chosen to recreate this condition and 50Chit/50Col 146 
mixture was set to represent the medium state between two extreme cases. It was 147 
reported that in the PA/PC complex the triple helix structure is preserved and even 148 
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reinforced by the presence of chitosan, but in the HC complex chitosan chains seem to 149 
induce the destabilisation of the triple helix organization and so denature the collagen.  150 
 Taking into account the possibility of these types of interactions occurring 151 
between collagen and chitosan, and by changing component ratios, scaffolds with 152 
different swelling/degradation kinetics and different mechanical properties should be 153 
expected to be formed. By changing crosslinking conditions using different chemical 154 
treatments it was foreseen that a further variation of properties could be achieved. 155 
Consequently, a wide battery of structures with different physicochemical behaviours 156 
were obtained and characterized in terms of morphology, degradation, swelling, 157 
mechanical properties, and also in terms of preliminary cytotoxicity to consider the 158 
possibility of performing further biological studies. 159 
 160 
2. MATERIALS AND METHODS 161 
 2.1 Materials 162 
 Type I microfibrillar collagen derived from bovine Achilles tendon, chitosan 163 
(medium molecular weight, viscosity 200-800 cps, 75% deacetylated), N-164 
Hydroxysuccinimide (NHS), 1-ethyl-3-(3-dimethylaminopropyl)carbo-diimide 165 
hydrochloride (EDAC), sodium tripolyphosphate (TPP), lysozyme from chicken egg 166 
white (40,000 U/mg), collagenase from Clostridium histolyticum type IA (125 U/mg), 167 
methylthiazoletetrazolium (MTT) and dimethylsulphoxide (DMSO) were purchased 168 
from Sigma-Aldrich (Barcelona, Spain). Acetic acid, absolute ethanol, potassium di-169 
hydrogenphosphate, dehydrated di-sodium hydrogenphosphate and hydrochloric acid 170 
(HCl) were purchased from Panreac (Barcelona, Spain). Fetal bovine serum (FBS), 171 
Dulbecco´s modified Eagle´s medium (DMEM), penicillin (50 U/mL), streptomycin (50 172 
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µg/mL), L-glutamine (200mM) gentamicin (50 µg/mL) and 0.05% trypsin/0.53 mM 173 
EDTA were purchased from Lonza (Barcelona, Spain). 174 
 175 
 2.2 Chitosan/Collagen scaffold preparation 176 
 Porous scaffolds based on chitosan/collagen mixtures were prepared using a 177 
freeze-drying process. Firstly, a pure solution of chitosan and a suspension of collagen 178 
were prepared at 1% (w/v) concentration in acetic acid. Chitosan was dissolved in 0.5M 179 
acetic acid and centrifuged (Ortoalresa, Digicen 20-R) at 3000 rpm for 5 min to remove 180 
any solid impurities. Collagen was allowed to swell in 0.05 M acetic acid at 4-8°C 181 
overnight to produce a 1% (w/v) protein suspension. The resulting suspension was 182 
homogenised on ice for 30 minutes at 20,000 rpm using an overhead homogenizer 183 
(Ultra-turrax® IKA T18 basic). Air bubbles were removed by centrifuging at 2500 rpm 184 
for 5 min (Hermle Z300, Labortechnik, Germany).  185 
 Three mixed scaffold compositions with different volume percentages (v/v) of 186 
polymers, namely, 80% chitosan and 20% collagen (80Chit/20Col), 50% chitosan and 187 
50% collagen (50Chit/50Col), and 20% chitosan and 80% collagen (20Chit/80Col), 188 
were produced by blending the corresponding polymer mixture at 20,000 rpm for 10 189 
min in an ice bath and then centrifuging at 2500 rpm for 5 min to remove air bubbles. 190 
Chitosan/collagen suspensions were then poured into 24 well cell culture plates, frozen 191 
at -20°C overnight and freeze-dried for 72 hours at -110°C to ensure their complete 192 
drying (Heto PowerDryLL1500 Freeze Dryer, Thermo Electron Corporation).  193 
 194 
 2.3 Scaffold crosslinking 195 
 Freeze-dried chitosan/collagen scaffolds were crosslinked (XL) to increase their 196 
strength and degradation resistance using different methods. In the first method 197 
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scaffolds were treated with a water-soluble carbodiimide (Park, Park, Kim, Song & Suh, 198 
2002) by immersing them in 95% ethanol solution containing 33 mM EDAC and 6 mM 199 
NHS for 2 h at 25°C (0.32 g EDAC/g scaffold and 0.35 g NHS/g scaffold, 200 
approximately). After the crosslinking process, the samples were washed sequentially in 201 
96% (v/v), 70% and 50% ethanol for 10 min in each solution, following by a final 202 
washing with distilled water (10min x 3). In the second method the scaffolds were first 203 
stabilized with ethanol by immersing in 96% and then 70% ethanol for 1.5 h in each 204 
solution followed by washing with distilled water. Following this, the samples were 205 
treated with 1% TPP solution in distilled water (w/v, pH 3.3) for 2 h at 25°C (0.5 g 206 
TPP/g scaffold approximately) and thoroughly washed in distilled water (10min x 6). 207 
Finally, a third crosslinking method was carried out combining EDAC and TPP. 208 
Scaffolds were immersed in 95% ethanol solution containing 33 mM EDAC and 6 mM 209 
NHS for 2 h at 25°C. After alcoholic and aqueous washings, the scaffolds were 210 
immersed in 1% TPP solution for 2 h and finally washed with water. At the end of each 211 
crosslinking method, the scaffolds were refrozen and re-lyophilized using the previous 212 
freeze-drying cycle. 213 
 214 
 2.4 Scaffold morphology 215 
 Scaffold pore structure and pore size distribution were analysed by scanning 216 
electron microscopy (SEM). Each sample was cut through the thickness of the scaffold 217 
sheet and cross-section samples were then mounted on stubs and sputtered with an ultra-218 
thin layer of platinum for 2 min at 20 mA. The samples were then studied with a JEOL 219 
5800 scanning electron microscope operating at 10 kV. The average pore size was 220 
obtained by measuring the maximum and minimum diameter in the image section of at 221 
least 30 pores randomly chosen in each sample. 222 
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 Porosity values were obtained using the following equation (Kumar, Batra, 223 
Kadam & Mulik, 2013): 224 
                                                         P (%) = (1-ρr) x 100                                       (1) 225 
 P being the porosity percentage value, and ρr the relative density value. 226 
 The relative density of each scaffold, ρr ,  was defined as: 227 
                                                    ρr = ρ
*
 / ρs                                                                      (2) 228 
where ρ* represents the dry density of each freeze-dried sample, and ρs is obtained from 229 
the known dry densities of solid collagen (ρs = 1.3 g·cm
-3
) (Khor, 1997) and chitosan (ρs 230 
= 0.5 g·cm
-3
) (Chatterjee, Lee, Lee & Woo, 2009).  231 
 In order to calculate the ρ* value, the mass and volume of each sample were 232 
determined after the freeze-drying process, and changes in these parameters, caused by 233 
the crosslinking process, were also evaluated using the following equations:  234 
                    Volume Shrinkage (%) = 100 × [(V0 − V)/V0]                                           (3)  235 
where V0 and V are the volumes of the scaffold before and after crosslinking, 236 
respectively; 237 
                       Mass Loss (%) = 100 × [(m0 − m)/m0]                                                     (4) 238 
where m0 and m are the masses before and after crosslinking, respectively.  239 
 240 
 2.5 Dissolution study 241 
 Crosslinked and non-chemically crosslinked (Non-XL) samples were hydrated 242 
in PBS (Phosphate Buffer Saline, pH 7.4) at 37°C to evaluate their degree of 243 
dissolution. Scaffolds were cut to approximate cuboids (8 × 8 × 18 mm), weighed prior 244 
to the dissolution study (Wd´), and then immersed in 2 ml PBS at 37°C for up to 14 days. 245 
At different time points they were removed, washed in a large volume of deionised 246 
water to remove buffer salts, and dried at 37°C until constant mass was reached. Finally, 247 
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the samples were weighed (Wa) and the percentage weight loss was calculated as 248 
follows: 249 
                       Weight loss (%) = 100 x [(Wd´ - Wa)/ Wd´]                                               (5) 250 
The pH value of the PBS was measured at each time point using a pH-meter 251 
(METROHM 654). Each sample was measured in quadruplicate.   252 
 253 
 2.6 Swelling study 254 
 This study was carried out in PBS. Scaffolds were cut to approximate cuboids (8 255 
× 8 × 18 mm), weighed and then immersed in 2 ml PBS at 37°C for up to 14 days. At 256 
different time points, they were removed and two different measurements of their 257 
capacity to retain biological fluid were made. The first measurement was aimed at 258 
assessing the ability of the scaffold structure as a whole (the material itself together with 259 
the pore system) to absorb PBS. For this, at each time point, the samples were removed 260 
from PBS, shaken gently and then weighed without dripping (Wws). The second 261 
measurement was carried out after pressing and ‘‘drying” the same soaked samples 262 
between sheets of filter paper to remove the water retained in its porous structure 263 
(Wwm). In this way the swelling ability of scaffold material itself was determined. The 264 
scaffolds were then dried at 37°C until constant mass was reached (Wd).  265 
 The percentage of fluid uptake, in both cases, was calculated as shown: 266 
                        Fluid uptake of scaffolds % = [(Ww - Wd)/Wd] x 100                          (6) 267 
where Ww represents Wws or Wwm. 268 
Each sample was measured in quadruplicate.  269 
 270 
2.7 Mechanical test 271 
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 A compressive stress-strain study of the scaffolds was carried out with a 272 
Hounsfield tester, using a 5 N load cell for the study and applying a constant 273 
compressive rate of 5 mm min
-1
. Prior to the compressive test, scaffold cuboids (8 × 8 × 274 
18 mm) were immersed in distilled water at room temperature for 1h. Compression 275 
platens were lowered to make contact with the samples, so producing a detectable and 276 
small load, and then the samples were compressed until densification occurred, at which 277 
point the tests were stopped. Stress-strain curves were drawn and used to calculate the 278 
linear elastic (Young´s) modulus via linear regression of the initial linear region of the 279 
respective curve (strain ranged approximately between 0.05-0.2). Each scaffold 280 
composition was assayed in quintuplicate, and three consecutive tests were also 281 
performed on each sample to study its capacity to maintain the mechanical properties 282 
after several compressions. 283 
 284 
2.8 In vitro collagenase and lysozyme degradation tests 285 
 Two digestion tests were performed in the presence of collagenase and 286 
lysozyme, respectively, in order to study the biological stability of the scaffolds. 287 
Scaffolds were cut to approximate cuboids (8 × 8 × 18 mm) and were weighed before 288 
the degradation studies (Wb). For the collagenase test, the samples were immersed in 289 
2ml PBS containing 160 µg/ml of collagenase while, in the case of lysozyme, the 290 
samples were immersed in 2ml PBS containing 1 mg/ml of lysozyme. The samples 291 
were then incubated at 37°C for up to 10 days.  At different time points, they were 292 
removed, washed in a large volume of deionised water and dried at 37°C until constant 293 
mass was reached. Finally, the samples were weighed (We) and the percentage weight 294 
loss was calculated as follows: 295 
                       Weight loss (%) = 100 x [(Wb – We)/ Wb]                                                (7) 296 
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Each study was performed in quadruplicate. 297 
 298 
2.9 Cell culture assays 299 
 2.9.1 Cell line and maintenance 300 
 Human breast adenocarcinoma MCF-7 cells were selected for preliminary 301 
testing of the cytocompatibility of the prepared structures.  MCF-7 cells were obtained 302 
from Dr. von Kobbe between 20 and 25 passage numbers, whose original source was 303 
ATCC®. Cells were maintained in Dulbecco’s modified Eagle medium, supplemented 304 
with 10% heat inactivated FBS, penicillin (50 U/mL), streptomycin (50 μg/mL), L-305 
glutamine (200 mM) and gentamicin (50 μg/mL) in a humidified incubator at 37°C and 306 
5% CO2 atmosphere (HERA cell, Sorvall Heraeus, Kendro Laboratory Products Gmbh, 307 
Hanau, Germany). The cells were plated in a 75-cm
2
 flask (Sarstedt Ag and Co., 308 
Barcelona, Spain) and were passaged when reaching 95% confluence, by gentle 309 
trypsinization. According to the results obtained from characterization studies, the 310 
scaffolds which offered better bulk characteristics were tested with cells. Thus, TPP-XL 311 
and EDAC+TPP-XL samples were selected for 80Chit/20Col and 50Chit/50Col 312 
compositions, whereas Non-XL and EDAC+TPP-XL samples were chosen for 313 
20Chit/80Col mixture.  314 
 2.9.2 Cell culture and seeding on chitosan/collagen scaffolds 315 
 Prior to the seeding, the scaffolds were cut to approximate cuboids (8 × 8 × 9 316 
mm), sterilized with ethanol and pre-incubated with DMEM supplemented with 317 
25%FBS for 30min at 37°C.  Samples were then placed on to Petri plates covered with 318 
sterilized parafilm for them to be inoculated with cells. 2x10
5 
MCF-7 cells in 200 µl 319 
medium with 10% FBS were seeded on to the scaffold surface and incubated for 1h to 320 
achieve cell attachment to the scaffolds. After this time, the inoculated samples were 321 
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moved to Petri plates containing 10 ml of DMEM with 10% FBS, and were incubated 322 
for up to 5 days.  Some samples were not inoculated with cells but followed the same 323 
protocol for use as controls.  324 
 2.9.3 Cell proliferation and growth kinetics study 325 
 Proliferation of MCF-7 cells on the scaffolds was quantitatively assessed with 3-326 
[4,5-dimethylthiazol-2-yl]-diphenyltetrazolium bromide (MTT) (Seda Tigli, Karakecili 327 
& Gumusderelioglu, 2007) at different culture periods of up to 5 days. At different 328 
culture times, control and inoculated samples were removed from the Petri plates and 329 
placed on to 24-well plates containing 1ml medium per well. Then, 100 µl MTT 330 
solution (5 mg/ml in PBS) was added to each well. The samples were incubated at 37°C 331 
for 2h. After this the medium was removed and 200 µl DMSO were added to dissolve 332 
formazan crystals. The absorbance was measured by a spectrophotometer at 570 nm 333 
(Varioskan, Thermo Fisher Scientific, Barcelona, Spain). MTT assay was also applied 334 
to the scaffolds without cells and the signal obtained was subtracted from the inoculated 335 
scaffold signal. Exponential cell growth was assumed and a specific growth rate (µ) was 336 
determined by fitting the following equation to the absorbance data (Seda Tigli, 337 
Karakecili & Gumusderelioglu, 2007): 338 
                                            ln (A/A0) = µ (t-t0)                                                             (8) 339 
where A0 is the initial absorbance at t0 (h), A is the absorbance at t (h) and µ is the 340 
specific growth rate (h
-1
). Four samples of each composition (n = 4) were tested at each 341 
experiment, and the assay was performed in triplicate. 342 
 343 
2.10 Statistical analysis 344 
 Statistical comparisons were performed using one way analysis of variance 345 
(ANOVA) followed by Bonferroni post hoc analysis with computer software SPSS 346 
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19.0. Values of p<0.05 and p<0.01 were considered significant and very significant, 347 
respectively. 348 
 349 
3. RESULTS  350 
 3.1 Scaffold morphology 351 
 The influence of composition and crosslinking methods on pore morphology 352 
was studied by SEM. Fig.1 shows SEM low magnification images of transverse scaffold 353 
sections.  354 
 355 
 356 
Fig. 1. SEM micrographs of the transversal sections of freeze-dried scaffolds with 357 
different compositions and different crosslinking treatments.  358 
 359 
 A continuous structure of interconnected pores with mainly uniform distribution 360 
was obtained in the three compositions, and was retained after crosslinking treatments. 361 
It was observed that pore shape tended to be rounded in all cases, since the same 362 
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freezing conditions were used for their production. The average pore size and porosity 363 
values are shown in Table 1. The pore dimensions estimated from SEM 364 
microphotographs were mostly in the range of 120-300 µm for all studied compositions 365 
and XL status. All scaffolds were highly porous; porosity values in the interval of ~ 96-366 
99% were obtained for all compositions. It was observed that the variation in 367 
composition affected scaffold dimensional properties: for Non-XL samples the pore size 368 
and porosity increased with the increase of collagen percentage in the scaffold mixture.  369 
 370 
Table 1. Morphological characteristics of the scaffolds pre- and post-crosslinking. 371 
 372 
Composition Porosity Pore size Shrinkage Mass loss 
  (%) (µm) (%) (%) 
     80Chit/20Col nX 97.9 ± 0.2 168 ± 54 
  80Chit/20Col EDAC 97.9 ± 0.3 197 ± 57 (-)3 (-)3 
80Chit/20Col TPP 95.9 ± 0.4* 120 ± 42* 43* (-)10* 
80Chit/20Col EDAC+TPP 96.2 ± 0.4* 191 ± 45 38* (-)12* 
     
     50Chit/50Col nX 98.4 ± 0.1 143 ± 44 
  50Chit/50Col EDAC 98.02 ± 0.08* 191 ± 47 18* (-)4 
50Chit/50Col TPP 97.8 ± 0.2* 194 ± 52 22* (-)10 
50Chit/50Col EDAC+TPP 97.8 ± 0.1* 258 ± 60 22* (-)9 
     
     20Chit/80Col nX 98.8 ± 0.1 262 ± 79 
  20Chit/80Col EDAC 99.06 ± 0.05* 248 ± 73 (-)3 21* 
20Chit/80Col TPP 98.7 ± 0.1 305 ± 80 20* 16* 
20Chit/80Col EDAC+TPP 98.77 ± 0.08 281 ± 72 4 3 
     * Indicates a statistical difference (p<0.05) in comparison to a non-chemically 
crosslinked sample of the same composition. Values of porosity and pore size are 
presented as mean ± standard deviation 
  
  
  
 Regarding the possible influence of crosslinking method over pore size and 373 
porosity, it was observed that EDAC and EDAC+TPP treatments did not introduce any 374 
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substantial changes in pore size compared to Non-Xl samples. However, TPP treatment 375 
caused a significant (p<0.05) reduction in the pore size and in porosity values of the 376 
scaffolds with the highest chitosan content (80Chit/20Col) (Fig.1 and Table 1). 377 
 378 
3.2 Dissolution study 379 
 The resistance of scaffolds to dissolution in PBS at 37ºC was strongly dependent 380 
on the composition and crosslinking treatment, as shown in Fig 2.  381 
 382 
 383 
Fig. 2. Weight loss (%) of scaffolds in PBS at 37ºC according to composition and 384 
crosslinking status. * means that statistical differences were found (p < 0.05) (n = 4; bar 385 
charts represent standard deviation values). 386 
 387 
 For Non-XL samples (Fig 2) the percentage mass loss was significantly higher 388 
for scaffolds with the highest chitosan content (80Chit/20Col). The differences in the 389 
dissolution profiles were more noticeable at the early incubation stage (up to one week) 390 
but on day 14 all Non-XL matrices reached a similar level of dissolution, 50Chit/50Col 391 
and 20Chit/80Col compositions being more stable with 55 and 63% of mass loss, 392 
respectively, compared to ~80% dissolution for 80Chit/20Col.  393 
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 Carbodiimide and TPP treatments generally increased the degradation resistance 394 
of all scaffold compositions in a biological fluid (Fig.2) but the level of stabilisation was 395 
highly dependent on scaffold composition and on XL method. For scaffold with the 396 
highest Chit content (80Chit/20Col) TPP treatment was the most effective, followed by 397 
combination of EDAC+TPP and EDAC alone (23% , 36% and 40% mass loss after 14 398 
days, respectively). For the 50Chit/50Col composition, all crosslinking methods 399 
provided similar values (~33%) of scaffold degradation after 14 days in PBS, TPP being 400 
the most effective at early incubation phase (up to 7 days). In the case of collagen 401 
enriched composition (20Chit/80Col), TPP treatment showed no effect on scaffolds 402 
resistance to dissolution as no significant differences were observed between non-XL 403 
and TPP-XL samples. However, the carbodiimide chemistry, alone or in combination 404 
with TPP, enhanced scaffold resistance to dissolution, thus providing the lowest 405 
degradation values after these treatments.  406 
 The hydrolytic degradation of Non-XL crosslinked and crosslinked scaffolds did 407 
not cause a significant change in pH value, this being maintained in a range of 6.5 and 408 
7.8 throughout the whole experiment. 409 
 410 
 3.3 Swelling study 411 
 The results of scaffold PBS-absorption ability are presented in Fig. 3, where 412 
swelling characteristics related to fluid retained both by the whole scaffold structure 413 
(overall uptake), and by the scaffold material itself, are displayed. In general, all 414 
scaffolds showed good capacity for overall PBS uptake. However, differences were 415 
observed according to the composition and crosslinking method employed. 416 
 In the case of Non-XL samples, the higher the chitosan content the bigger was 417 
the value of the overall fluid uptake at the early incubation time: 80Chit/20Col scaffolds 418 
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reached the maximum swelling degree (~11000%) after the first 24 hours, which was 419 
twice higher than for 50Chit/50Col matrices, and almost four times bigger than in the 420 
case of 20Chit/80Col (Fig. 3). However, after this time point both chitosan enriched 421 
compositions progressively lost their PBS absorption properties, these reaching the 422 
minimum values at day 14: in the case of 80Chit/20Col the decrease amounted to ~6 423 
fold whereas for 50Chit/50Col to~10 times. This reflects pore collapse and loss of 424 
scaffold material to the medium. An opposite tendency was observed in the case of 425 
scaffolds with the highest Col content: 20Chit/80Col Non-XL composition steadily 426 
increased its swelling capacity over a period of 14 days incubation and reached the 427 
maximum value (~6000%) at the end of the testing period (day 14).  428 
 In order to assess the influence of the crosslinking method on PBS uptake 429 
properties, samples treated with different reagents were compared at each composition. 430 
It was observed that all XL methods influenced scaffold swelling behaviour and that the 431 
crosslinking effect on PBS uptake was noticeably dependent on both the composition 432 
and the XL treatment. For example, swelling profiles of 80% and 50% chitosan-based 433 
scaffolds treated with EDAC showed that both compositions arrived at their maximum 434 
swelling degree (as a whole structure) within the first 24 hours and 3 days in PBS, 435 
respectively, followed by a gradual decrease of this parameter, which was more marked 436 
for 80Chit/20Col composition (almost twofold, Fig 3). TPP treatment, alone or in 437 
combination with EDAC, enhanced the overall swelling capacity of both Chit-enriched 438 
compositions, significantly increasing their values of PBS uptake. For 20Chit/80Col 439 
samples, very pronounced time increasing profiles of PBS absorption were observed 440 
after all the three crosslinking treatments, the combination of EDAC and TPP being the 441 
method providing the highest value of fluid uptake (~10000%). This value was almost 442 
twice higher than for any other composition treated by any XL method.  443 
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 444 
 445 
Fig. 3. Fluid uptake (%) of the whole scaffold and scaffold material in PBS at 37ºC 446 
according to composition and crosslinking status: after 1 hour ( ), after 1 day         447 
( ), after 3 days ( ), after 7 days ( ), after 10 days ( ) and after 14 448 
days ( ).* means that statistical differences were found (p < 0.05) between values 449 
at the beginning and the end of the experiment. ♯ indicates the compositions with 450 
significant restricted swelling behaviour due crosslinking action. (n = 4; bar charts 451 
represent standard deviation values). 452 
 453 
 454 
 Scaffold swelling abilities of material alone of untreated samples showed the 455 
same tendencies as those observed for the overall fluid uptake: for matrices with 50 and 456 
80% of chitosan maximum fluid absorption occurred within the first 24 hours and then 457 
the percentage of material swelling fell gradually over 14 days from 5000% to ~500% 458 
and from 2000% to ~200% for 80Chit/20Col and 50Chit/50Col, respectively. This 459 
significant decrease in absorption capacity may be a consequence of chitosan migration 460 
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from scaffold to medium. Col-enriched compositions showed an almost time-461 
independent swelling profile which reached the maximum value within the first 24 462 
hours, and then remained stable for up to 14 days, this being a sign of the material 463 
stability of this composition in physiological medium up to prolonged incubation time.  464 
TPP treatment, alone or with EDAC, markedly decreased the swelling capacity of all 465 
scaffolds at early incubation stage (up to 24 hours) and for the samples with the 466 
maximum chitosan content over all the period (up to 14 days). This 80%-Chit 467 
composition showed, however, time-independent material swelling profiles after EDAC 468 
crosslinking, while 50%-Chit EDAC treated samples began to lose part of their PBS 469 
absorption ability after 3 days of incubation. For both 50 and 80%Chit-based scaffolds 470 
material swelling was increasing with the time of incubation when these matrices were 471 
exposed to TPP or TPP+EDAC. In the case of 20Chit/80Col scaffolds, all crosslinked 472 
samples showed a similar behaviour. Although a slight decrease in PBS absorption was 473 
detected during the first hours for samples exposed to TPP-based treatments, similar 474 
swelling levels were then reached for all XL methods after 14 days in PBS.  475 
 476 
 3.4 Mechanical testing 477 
 Fig.4 (A-C) shows stress-strain curves of scaffolds with different compositions 478 
and crosslinking statuses. Young´s moduli calculated from the initial parts of these 479 
curves are presented in Table 2.  480 
 The influence of composition on the mechanical properties of scaffolds was 481 
analysed by comparing the values of Young´s modulus of Non-XL samples. Results in 482 
Table 2 showed that the increase in chitosan from 20 to 50% in scaffold composition 483 
resulted in significant enhancement (~50%) of the values of elastic modulus (from 4.5 484 
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to 6.9 kPa, for 20Chit/80Col and 50Chit/50Col, respectively) but the further increase in 485 
Chit content caused decrease (~20%) of this parameter. 486 
 487 
Fig. 4. Stress-strain curves for hydrated non-chemically crosslinked and crosslinked 488 
scaffolds tested under compression at 5 mm min
-1
 at room temperature: (A) 489 
80Chit/20Col; (B) 50Chit/50Col and (C) 20Chit/80Col. (D) Typical profile of a stress-490 
strain curve of three repeat tests of the same scaffold specimen (n = 5). 491 
 492 
 Crosslinking significantly enhanced the resistance to compression of all 493 
compositions but the degree of this rise was dependent on the component ratio and on 494 
the method employed (Table 2). 495 
 496 
Table 2. Mechanical properties of scaffolds 497 
 498 
Young´s modulus  (kPa) (measured between 0.05-0.2 strain) 
  80Chit/20Col 50Chit/50Col 20Chit/80Col 
Not crosslinked 4.5 ± 0.3 6.9 ± 0.8 5.5 ± 0.2 
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EDAC 9.9 ± 0.4* 12 ± 1* 23 ± 2* 
TPP 20 ± 2* 11.7 ± 0.7* 15 ± 2* 
EDAC+TPP 7.7 ± 0.5* 11 ± 1* 24 ± 3* 
* Indicates a statistical difference in comparison to a non crosslinked 
sample of the same composition. 
 499 
 500 
 For the composition with the maximum chitosan content TPP provided the 501 
maximum increase (~4.5 fold) in Young’s modulus. EDAC treatment was noticeably 502 
less effective for this composition as the compressive modulus increased only  ~2.2 503 
times after EDAC exposure and even less (~1.8 times) after combined treatment with 504 
EDAC+TPP . In the case of the collagen-enriched composition, an opposite influence of 505 
XL methods on scaffold stiffness was observed: EDAC and EDAC+TPP induced the 506 
highest improvement in mechanical properties (~4.5fold rise) while TPP exposure 507 
resulted in a more modest increase in the compression modulus (~2.7 times). For the 508 
50Chit/50Col composition, all the treatments resulted in a similar increase in strength 509 
(~1.7fold).  510 
 In order to assess scaffold behaviour under successive compressions, the same 511 
sample specimens were repeatedly tested at least three times. These tests were carried 512 
out with all the crosslinked and Non-XL samples, excepting the 20Chit/80Col± EDAC-513 
XL samples, and the 50Chit/50Col EDAC-XL composition. In the case of these latter 514 
systems, the structure cracked after the first compression, which indicated that these 515 
compositions produce the most fragile matrices. Typical stress–strain curves 516 
corresponding to the other samples (Fig.4D) showed no significant changes in their 517 
profiles after successive compressions (curves almost overlay each other in all stain 518 
intervals). This indicates good ability for structural recovery for these compositions and 519 
XL status.  520 
 521 
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 3.5 In vitro collagenase and lysozyme degradation tests 522 
 Enzymatic degradation of chitosan/collagen scaffolds was studied by monitoring 523 
the residual mass percent of the samples after several days of incubation, separately, 524 
with the two enzymes collagenase and lysozyme. Figure 5 shows the percentage weight 525 
loss of chitosan/collagen sponges in collagenase and lysozyme solutions.  526 
 Non-XL scaffolds showed very poor resistance to enzymatic degradation in the 527 
presence of both enzymes. All samples lost almost 50% of weight within one hour in 528 
collagenase, while after 24 hours untreated samples were almost completely dissolved 529 
(80-100% mass loss).  530 
 In lysozyme, all compositions were more stable at the first hour of incubation, 531 
50Chit/50Col sample being more resistant to digestion after prolonged incubation time 532 
(~60% mass loss after 10 days compared to 80-90% for the other two compositions). 533 
Crosslinking with TPP alone or in combination with EDAC significantly increased the 534 
resistance of all scaffold compositions to enzymatic degradation in the presence of 535 
lysozyme, while EDAC alone was effective only for 50% and 80% collagen-based 536 
scaffolds.  537 
 In collagenase, none of the employed treatments provided effective stabilisation 538 
of scaffolds with 80%-collagen content. For this composition the improvement in 539 
degradation stability was noticeable only for the very early stage of incubation in 540 
collagenase but after 3 days the scaffolds lost almost the same amount of material as 541 
Non-XL samples. Crosslinking, however, could, to some extent, protect the chitosan-542 
enriched compositions against collagenase digestion, especially when TPP or TPP with 543 
EDAC were employed for scaffold treatment. The lowest values of mass loss were 544 
obtained for 50-50% composition after combined EDAC+TPP treatment (less than 40% 545 
degradation after 10 days of incubation). 546 
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 547 
 548 
Fig. 5. Weight loss (%) in the presence of collagenase and lysozyme in PBS at 37ºC for 549 
scaffolds with different composition and crosslinking treatment: after 1 hour ( ), 550 
after 1 day ( ), after 3 days ( ), after 7 days ( ), after 10 days ( ). 551 
* means that results obtained from TPP and EDAC+TPP treated samples were 552 
significantly different (p < 0.05) from EDAC treated samples. (n = 4; bar charts 553 
represent standard deviation values). 554 
 555 
3.6 Cell culture assays 556 
 The viability and proliferation of MCF-7 cells on selected chitosan/collagen 557 
scaffolds were evaluated over 5 days of incubation. Results were presented as the 558 
optical density, determined by MTT assay (Fig. 6). Control signals were subtracted 559 
from each composition’s data.  560 
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 561 
Fig. 6. Proliferation trends and cell viability of MCF-7 cells on chitosan/collagen 562 
scaffolds by MTT measurements: after 1h ( ), 24h ( ), 48h ( ), 96h (563 
) and 120h  ( ). ∆ marks the composition without time-dependent growth. (n = 564 
3; bar charts represent standard deviation values). 565 
 566 
 567 
 In general all scaffolds were found to be cytocompatible and adequate for cell 568 
culturing. Cells started to proliferate on the scaffolds after 24 h of incubation in almost 569 
all compositions, and continued growing for up to 4 days of incubation. Only the 570 
80Chit/20Col EDAC+TPP-XL composition showed an irregular proliferation trend 571 
without significant differences in the growth of cells from the first 24h of incubation. 572 
On the contrary, cells continued growing until the end of the experiment on 573 
50Chit/50Col and 20Chit/80Col EDAC+TPP-XL scaffolds. 574 
 In order to quantify the MCF-7 cell proliferation, specific growth rates (µ) were 575 
determined by Eq. 9 and presented in Table 3. Doubling time values were also given in 576 
this table. These parameters are usually determined to measure cell proliferation. It was 577 
observed that the highest cell proliferation rate and, consequently, the lowest doubling 578 
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time were achieved in the case of 50Chit/50Col TPP-XL samples (Table 3). This 579 
composition seemed to be the most suitable for obtaining fast and time-dependent cell 580 
growth. However, this composition was followed closely by 80Chit/20Col TPP-XL, 581 
50Chit/50Col EDAC+TPP and 20Chit/80Col Non-Crosslinked scaffolds which also 582 
produced good results in the parameters of cell proliferation.  583 
 584 
Table 3. MCF-7 cell growth kinetic parameters. 585 
 586 
Composition Specific growth rate (µ, h
-1
) Doubling time (td, h) 
80Chit/20Col TPP 0.0155 (0.940) 44.7 
80Chit/20Col EDAC+TPP 0.0046 (0.999) 150.7 
50Chit/50Col TPP 0.0190 (0.999) 36.5 
50Chit/50Col EDAC+TPP 0.0145 (0.960) 47.8 
20Chit/80Col Non-Crosslinked 0.0147 (0.937) 47.1 
20Chit/80Col EDAC+TPP 0.0120 (0.960) 57.8 
Value in parenthesis means r
2 
(r
2 
: correlation coefficient resulted after linear fitting of values 587 
obtained in the graphical representation of time (X) and cell viability (absorbance ,Y). 588 
Exponential growth was assumed) 589 
 590 
4. DISCUSSION 591 
 The main objective of this study was to determine the effect of changing 592 
composition and crosslinking methods on both the essential material properties and the 593 
biological suitability of scaffolds obtained from different collagen-chitosan mixtures. 594 
Three compositions, covering a wide range of ratios were selected for scaffold 595 
production, namely, Chit/Col = 80/20, 50/50 and 20/80 (wt%/wt%). As previously 596 
explained, these compositions were chosen with the aim of inducing different kinds of 597 
interactions between two polymer components according to their fractions in the blend. 598 
The extent of complexation reactions and the influence of different crosslinking 599 
treatments were evaluated in terms of structural properties, swelling/dissolution 600 
kinetics, mechanical properties and also biocompatibility of the resultant scaffolds.  601 
 4.1 Morphology 602 
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 Chitosan-collagen blends were processed, using lyophilisation, to produce 603 
homogeneous, highly porous (porosity ~96-99%) isotropic scaffold architectures with 604 
pore diameters in the range 120-300m. The values of pore size were slightly dependent 605 
upon the polymer ratios which increased with increase of Col content. Crosslinking 606 
does not affect significantly scaffold morphology with the exception of those matrices 607 
obtained with the highest chitosan content and then treated with TPP, where a 608 
significant (p<0.05) reduction in the pore size was observed. Since TPP acts through 609 
ionic interactions with protonated amino groups of chitosan (Denkbas & Ottenbrite, 610 
2006), this reduction in pore size could be the result of inter-molecular bond formation, 611 
which is more pronounced in chitosan-enriched samples (80Chit/20Col). 612 
 Porosity in some cases was also affected to some extent by the crosslinking. 613 
Porosity index is dependent upon the relative density which, in turn, is a function of the 614 
volume of the sponge and the mass of its struts. In general, volume shrinkage may be 615 
expected if a crosslinking agent alters the relative position of scaffold struts by pulling 616 
them closer to each other, and so producing structural densification. Formation of inter-617 
fibre bonds during TPP treatment may explain volume shrinkage especially for the TPP-618 
XL Chit-enriched composition (80Chit/20Col). 619 
 Variation in mass is also a phenomenon which is frequently observed after 620 
different crosslinking procedures (Grover, Cameron & Best, 2012): strut mass may 621 
decrease in the case of material dissolution during the crosslinking process, or increase 622 
if the crosslinking reagent forms part of the linkage and  is in this way completely or 623 
partially incorporated into the scaffold composition. Carbodiimide chemistry works by 624 
promoting bonds between carboxylic and amine groups of the adjacent polypeptide 625 
chains without entering into the scaffold structure, therefore mass increase is not 626 
anticipated after this treatment (Olde Damink, Dijkstra, van Luyn, van Wachem, 627 
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Nieuwenhuis & Feijen, 1996b). TPP, however, uses its negatively charged phosphate 628 
ions to establish ionic interactions with positively charged amino groups of chitosan. 629 
This leads to the incorporation of the TPP molecules into the scaffold composition 630 
which should affect (increase) scaffold mass. At the same time, during crosslinking by 631 
any method, some mass loss may be expected as a result of polymer dissolution and 632 
migration of unattached polymer chains into the crosslinking/washing media 633 
(water/ethanol mixtures). Competition between these two processes, influencing 634 
scaffold mass in an opposing way, may explain the results of scaffold weight change 635 
after cross-linking: increase for Chit-enriched scaffolds mainly after TPP-base 636 
treatments and decrease in the case of 80% Col-containing compositions (Table 1). 637 
 Changes in volume and mass should, in turn, affect the relative density values 638 
and, consequently, scaffold porosity after XL procedures. Despite the observed 639 
significant differences (p<0.05) in scaffold mass and volume (Table 1) after 640 
crosslinking, especially those based on the TPP technique, a real effect on matrix 641 
porosity was confirmed only in the case of the chitosan enriched (80Chit/20Col) TPP-642 
XL composition. These changes were also observed in the SEM images of this sample 643 
(Fig.1). For the remaining scaffolds, the detected variations were not significant, which 644 
could be result of combination and compensation of two opposite effects: volume 645 
shrinkage and mass changes after the crosslinking treatment.  646 
 In spite of the observed dimensional alterations, these treatments do not 647 
produced any noticeable detrimental effect on scaffold morphology: the pore size was 648 
within a range suitable for the growth of the variety of cell lines (myocytes, endothelial 649 
cells, fibroblasts, etc.), as reported in the literature (Gerdes, Moore, Hines, Kirkland & 650 
Bishop, 1986; Radisic & Vunjak-Novakovic, 2005; Wang et al., 2010a) and the porosity 651 
level, exceeded 90%, fell into the interval recommended for correct in vitro cell 652 
30 
 
adhesion, growth and reorganization, and also as the necessary space for in vivo 653 
neovascularisation (LeGeros, LeGeros & 1995). This means that the morphology of all 654 
matrices was appropriate for their potential use in different TE applications. 655 
 656 
4.2 Dissolution behaviour  657 
The resistance of scaffolds to dissolution, as expected, was strongly dependent 658 
upon composition and crosslinking treatment. In the case of non-XL samples, the better 659 
resistance to dissolution of collagen enriched scaffolds may be explained by a self-660 
cross-linking phenomenon, due to PA/PC complex formation, which should be favoured  661 
in composite scaffolds with appropriate, near to stoichiometric ratios (Sionkowska, 662 
Wisniewski, Skopinska, Kennedy & Wess, 2004). 20Chit/80Col composition shows an 663 
almost stoichiometric weight percentage between its components, according to reports 664 
by Taravel and Domard (Taravel & Domard, 1996), followed next by the 50Chit/50Col 665 
sample. The stronger component interactions, as expected in these matrices, could 666 
explain the observed stability of 20 and 50%-Chit-based scaffolds (Fig.2) towards 667 
dissolution. At prolonged incubation times (14 days), however, these PA/PC complexes 668 
might be not strong enough to resist hydrolysis, which may explain the increase in 669 
dissolution of these compositions over time. Differences in mass loss between 80%Chit 670 
samples and those of lower chitosan content (50 and 20%) decreased from ~40%, after 671 
the third day in PBS, to 23% and 13% for 50 and 20% Chit containing matrices, 672 
respectively, at the end of testing (14 days).  673 
Chemical crosslinking manages to stabilise almost all scaffold compositions in 674 
biological media but to a different degree.  The most significant effect of all 675 
crosslinking methods on scaffold stabilisation was observed for Chit-enriched 676 
composition (80Chit/20Col), the TPP treatment being, as expected, the most effective, 677 
especially in combination with EDAC. This may be explained by the fact that the 678 
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component ratio in 80Chit/20Col samples is too far from stoichiometric, which does not 679 
benefit PA/PC complex formation. This component proportion, however, may promote 680 
a hydrogen-bonding type complex (HC) which is favoured in matrices with a great 681 
excess of chitosan, as reported (Taravel & Domard, 1993, 1995, 1996). It was shown in 682 
the PA/PC complex that the triple helix Col structure is preserved, and even reinforced, 683 
by the presence of chitosan but, on the other hand, in the HC complex chitosan chains 684 
seem to induce destabilisation of the triple helix organization and to denature the 685 
collagen (Taravel & Domard, 1995). This means that untreated 80%Chit based 686 
composition should be the least stable compared with those with less Chit content, and 687 
as a result might be more favoured from the “external” linkage. The fact that chitosan, 688 
the major component (80%) of this composition, interacts mainly with TPP explains the 689 
strongest input of this treatment to the enhancement of matrix strength. It seems that 690 
EDAC additionally contributes to scaffold stability by promoting links in polypeptide 691 
chains of the remaining (20%) collagen component. For 50 and 20% Chit-based 692 
scaffolds the crosslinking effect on dissolution was quite small and became noticeable 693 
only from the third incubation day onwards when the differences between mass loss of 694 
Non-XL and XL samples become more significant, especially for 50Chit/50Col 695 
samples. In the case of 20Chit/80Col scaffolds, no significant differences were observed 696 
between Non-XL and TPP-XL samples while EDAC+TPP could slightly contribute to 697 
scaffold resistance to dissolution. These results may be explained by a clear self-698 
crosslinking effect, due to PA/PC complex formation, in both 50 and 20% Chit-based 699 
scaffolds. So, while crosslinking can to some extent improve resistance to dissolution of 700 
these self-cross-linked compositions, especially at prolonged time in an aqueous 701 
environment, the influence of chemical treatments was little, if any, in the case of 702 
80Col%, particularly over short incubation times. 703 
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 704 
4.3 Swelling properties 705 
The ability of scaffolds to hold biological fluids is a very important factor in the 706 
evaluation of scaffold suitability as cell delivery vehicles for different in vivo and in 707 
vitro TE procedures (Engler, Bacakova, Newman, Hategan, Griffin & Discher, 2004; 708 
Park, Lee, Lee & Suh, 2003). Swelling characteristics indicate how cell culture medium 709 
may be absorbed during culture and how the scaffold may behave in vivo. The results of 710 
PBS uptake studies showed that overall swelling characteristics of scaffolds and the 711 
adsorption properties of struts alone were highly dependent on scaffold composition and 712 
crosslinking treatment. It was revealed that Chit-enriched (80%Chit) Non XL samples 713 
admitted the highest amount of media into their structures at an early incubation stage,  714 
most probably due to a lower level of interaction with their polymeric network (less 715 
PA/PC complex than in other compositions, as already described). The steepest descent 716 
in overall swelling after 24 hours incubation, and the lowest values of media uptake at 717 
the end of the experiment of this 80% Chit composition, may be a consequence of pore 718 
collapse due to lack of structural strength of its 3D matrix. Material absorption 719 
properties of this composition showed the same tendency as overall fluid uptake: the 720 
highest values of strut swelling at an early stage of incubation, most likely attributable 721 
to the higher hydrophilicity of chitosan (80% in the mixture) in comparison to collagen, 722 
and an abrupt decrease in material swelling over time as a result of strut dissolution and 723 
diffusion of weakly-bonded polymeric chains into the media.  724 
Higher level of inter-molecular self-crosslinking in Col-enriched compositions 725 
in comparison with 20% Col samples, resulting in more tight and entangled internal 726 
structures, caused lower values of overall and material swelling at short incubation time 727 
to 50 and 80% Col Non-XL compositions. The increase of overall swelling profiles of 728 
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20Chit/80Col scaffolds with time may be explained by the highest extent of self- 729 
complexing in these matrices which provides them with stable media-holding 730 
characteristics over a prolonged incubation period. Gradual increase in absorption 731 
capacity during incubation may be a consequence of strut swelling, leading to loosening 732 
of the polymeric network which should increase its overall swelling capacity. 733 
The influence of the crosslinking method on PBS uptake properties of composite 734 
scaffolds may also be explained by the extent of complex formation reactions in the 735 
matrices with different component ratios. Swelling behaviour of 80% and 50% 736 
chitosan-based scaffolds was more affected by chemical treatment, especially at 737 
prolonged incubation times. The descending profile of overall swelling after 24hours 738 
incubation of Chit-enriched EDAC-XL samples and the ascending tendency of these 739 
matrices after TPP+EDAC treatments, showed the importance of Chit-TPP interactions 740 
in the enhancement of the structural strength of their less self-bonded networks. Strut 741 
swelling at prolonged incubation time, leading to relaxation of chemically treated 742 
structures, may explain the rise in the degree of swelling with increase in time. For 743 
20Chit/80Col scaffolds the highest value of fluid uptake at 14 days incubation (an 744 
almost twofold increase compared to Non-XL sample and to any other XL composition) 745 
pointed to a higher level of stability of bonds formed by crosslinking compared with 746 
those achieved by complexing reactions between chitosan and collagen. Crosslinking 747 
treatments decreased the level of the swelling capacities of the material itself at the early 748 
stages of incubation (up to 24 hour) for all compositions. This may be explained by a 749 
decrease in hydrophilicity of scaffold material after crosslinking due to (a) the 750 
consumption of groups involved in water uptake during the crosslinking process 751 
(carboxylic and amino groups) and (b) restraint in the ability to swell by formation of 752 
additional bonds.  These results are in agreement with reports (Charulatha & Rajaram, 753 
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2003; Rehakova, Bakos, Vizarova, Soldan & Jurickova, 1996) showing that with an 754 
increase in crosslinking densities swelling of material itself of Col-based scaffolds 755 
decreased.  756 
 757 
4.4 Mechanics 758 
The development of scaffolds with adequate mechanical properties is one of the 759 
greatest challenges in the design of tissue engineering constructs. Intense research has 760 
shown that scaffold compressive properties, such as Young’s modulus and the 761 
compressive strength, have a great impact on the cellular activity during culturing. 762 
Appropriate compressive properties prevent scaffolds from collapsing as a result of 763 
cellular action within their matrices (Harley, Leung, Silva & Gibson, 2007; Horan et al., 764 
2005). On the other hand, it is clear that scaffold mechanics should be adjusted to 765 
closely resemble the environment of extracellular matrices in order to encourage cells to 766 
generate new artificial tissue and enhance repair. This demonstrates the importance of 767 
developing strategies to modulate scaffold mechanics according to the biological 768 
requirements of a specific application. In this work the variety of compressive 769 
properties of 3D matrices were achieved by changing component ratios in Chit/Col 770 
scaffolds and by variations in their crosslinking procedures. Compression tests 771 
conducted in this study on the effect of composition on Young’s modulus revealed that 772 
the introduction of chitosan to collagen significantly increases the values of this 773 
parameter for all composite scaffolds compared  with pure Non-XL Col samples 774 
(1.2kPa) which were produced and tested for comparison purposes. After EDAC 775 
treatment of Chit/Col scaffolds under optimum crosslinking conditions (EDAC 776 
11.5mg/ml, molar ratios EDAC/NHS/COO
-
(Col) = 5/2/1)(Olde Damink, Dijkstra, van 777 
Luyn, van Wachem, Nieuwenhuis & Feijen, 1996a; Park, Park, Kim, Song & Suh, 778 
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2002) their Young’s modulus increased to 6.2kPa (data not shown) and reached the 779 
same level as for Non-XL Col-Chit composite matrices (between 4.5 and 6.9kPa). This 780 
revealed the importance of electrostatic interactions between scaffold components in 781 
blended compositions in order to enhance matrix compressive properties. The maximum 782 
value of elastic modulus was achieved when polymers were combined in equal 783 
proportions (1:1 Chit/Col w/w%). This indicates that 50Chit/50Col composition 784 
provides maximum stiffness to scaffold struts probably by the higher degree of 785 
formation of a complex between Col and Chit. The increase of compressive modulus of 786 
collagen-chitosan composite scaffolds was reported in the literature where better 787 
material stabilisation in terms of compression was achieved at a ratio of 1:2 chitosan-788 
collagen (Arpornmaeklong, Pripatnanont & Suwatwirote, 2008; Chicatun et al., 2011). 789 
Crosslinking usually increases the stiffness of the biopolymer matrices by 790 
introducing additional linkage within the polymeric network which, in turn, enhances its 791 
resistance to dimensional changes under compression (Olde Damink, Dijkstra, van 792 
Luyn, van Wachem, Nieuwenhuis & Feijen, 1996a; Park, Park, Kim, Song & Suh, 793 
2002). A similar effect of chemical treatment on scaffold compression properties was 794 
observed in this study. The rise in modulus value was highly dependent upon the 795 
composition and crosslinking procedure. The results may be logically explained by 796 
differences in crosslinking degrees achieved in each composite sample exposed to TPP 797 
or EDAC-based treatments. As has already described, a scaffold with excess Chit in its 798 
composition should be more efficiently crosslinked by the TPP procedure, while 799 
matrices with higher Col content should be more favoured by EDAC-base treatment. 800 
The results of mechanical testing corroborate this explanation, as a higher level of 801 
improvement in Young’s modulus (~4.5 fold increase) was observed for Chit-enriched 802 
composition (80%Chit) after TPP treatment. EDAC, alone or with TPP, was less 803 
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effective and provided a lower (less than 2fold) rise in this parameter. In contrast, for 804 
80% Col scaffolds the most significant increase in compressive modulus (~4.4 fold) was 805 
observed after EDAC-based treatments. It is worth mentioning that although 806 
crosslinking did not produce any significant changes in term of dissolution resistance 807 
and swelling behaviour for the 20Chit/80Col composition, mechanical properties were 808 
highly dependent upon the crosslinking procedure. So it may be concluded that in 809 
general, scaffold stiffness could be effectively modulated by both composition and 810 
crosslinking in order to tailor the mechanics of these matrices towards specific TE 811 
application.  812 
 813 
4.5 Enzymatic degradation 814 
It is known that bacterial collagenase (Closrium hisrolyticum) specifically 815 
cleaves the peptide bond on the amino side of glycine in collagen sequences (Lee, Park, 816 
Hwang, Kim, Kim & Sub, 2001; Weadock, Miller, Keuffel & Dunn, 1996) while 817 
lysozyme hydrolyses and metabolises chitosan molecules, leading to the release of 818 
amino-sugars (Seda Tigli, Karakecili & Gumusderelioglu, 2007). Therefore it may be 819 
anticipated that Non-XL Chit enriched compositions should be degraded more in 820 
lysozyme containing media while scaffolds with higher collagen content should be more 821 
susceptible to the presence of collagenase (Harper & Kang, 1970). On the other hand, it 822 
may be expected that polyelectrolyte complex formation, being more favoured in a Col-823 
enriched composition, could to some extent protect composite scaffolds from enzymatic 824 
digestion. Results showed, however, very poor stability of all untreated compositions in 825 
the presence of enzymes, especially collagenase. Even 80%-Col samples, where almost 826 
all polymeric content should be involved in polyelectrolyte complexation, were almost 827 
completely dissolved after 24 hours in the presence of collagenase, in a way similar to 828 
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other compositions. This may indicate that linkage resulting from Chit/Col ionic 829 
interactions was not strong enough or/and the location of these bonds was not adequate 830 
to protect collagen sequences from enzymatic attack. 831 
Crosslinking usually improves the biostability of scaffolds in the presence of 832 
enzymes. EDAC treatment is reported as being highly efficient in increasing the 833 
resistance of collagen-based scaffold to collagenase digestion (Ma et al., 2003; Powell 834 
& Boyce, 2007; Zhu, Liu, Song, Jiang, Ma & Cui, 2009) Our results revealed, however, 835 
rather a limited improvement in scaffold stability in collagenase containing media after 836 
EDAC-based treatment, especially for 80% Col-containing compositions. Moreover, it 837 
was observed that none of the crosslinking methods could stabilise these Col-enriched 838 
scaffolds in the presence of collagenase. This may indicate that polyelectrolyte complex 839 
formed in Col-Chit scaffold with stoichiometric component ratio is responsible for low 840 
efficiency of EDAC and TPP treatments towards collagenase digestion. The amount of 841 
free amine/carboxylic groups on collagen left after PA/PC complex formation may be 842 
insufficient to achieve the formation of a high density network after treatment. The fact 843 
that pure Col scaffolds treated with EDAC showed very high resistance to collagenase 844 
digestion, by losing only ~8% weight after 14 days incubation (results not shown), 845 
contributes to this supposition. Chemical treatments, however, could stabilise 80% Col 846 
composition in the presence of lysozyme, which indicates that (a) some additional 847 
modification of chitosan takes place after crosslinking procedures and (b) crosslinks 848 
formed could prevent scaffolds from hydrolysis by lysozyme. In the case of the other 849 
two compositions, where Chit/Col ratios were further from stoichiometric, chemical 850 
crosslinking could noticeably contribute to scaffold stability in the presence of both 851 
collagenase and lysozyme. It seems that chitosan (polymer in excess) managed to form 852 
additional bonds, mainly with TPP, which may explain the better efficiency of TPP–853 
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based methods in scaffold stabilisation in the presence of both collagenase and 854 
lysozyme. The network formed by crosslinking, in addition, should prevent the 855 
enzymes, by steric hindrance, from accessing the active sites on the collagen and 856 
chitosan molecules, or by holding enzyme-cleaved chain sections intact.  857 
 858 
4.6 Cell studies 859 
Collagen and chitosan have been widely used as materials for the preparation of 860 
scaffolds where cells could be seeded and proliferate successfully, either used separately 861 
(Chen et al., 2012; Dhiman, Ray & Panda, 2004) or in combination (Zhu, Liu, Song, 862 
Jiang, Ma & Cui, 2009). In spite of the expected good cytocompatibility of scaffolds 863 
based on Chit/Col combination, the evaluation of cell viability is necessary to assess 864 
scaffold´s potential for TE applications. Therefore, MTT assay was performed to pre-865 
evaluate the proliferation rate of cells since this method has been extensively used for 866 
this purpose and reveals the extent of cellular metabolism and viability of the cells 867 
(Chung & Chang, 2010; Jin, Chen, Karageorgiou, Altman & Kaplan, 2004). 868 
Additionally, MCF-7 line has been also commonly selected to test the compatibility of 869 
different types of natural polymers with biomedical applications (Chen et al., 2012; 870 
Wang et al., 2010b). 871 
Taking into account the results obtained from in vitro studies, it was 872 
hypothesized that TPP-XL and EDAC+TPP-XL samples for 80Chit/20Col and 873 
50Chit/50Col compositions, and Non-XL and EDAC+TPP-XL for 20Chit/80Col 874 
mixture, would offered promising and suitable bulk characteristics for cell culture. The 875 
selection of Non-XL 20Chit/80Col scaffolds was based on the advantage which would 876 
be offered by the self-crosslinking phenomenon observed in this composition for cell 877 
culture studies. This particular behaviour would avoid the need for using additional 878 
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chemical reactants to obtain a stable 3D scaffold, which could be considered as an 879 
advantage to obtain more biocompatible structures.   880 
Our results confirmed the foreseen good compatibility of all scaffolds seeded 881 
with MCF-7 cells. The MTT reduction, which is considered as a marker reflecting 882 
viable cell metabolism, increased up to 4-5 days without significant decrease in any 883 
composition. Therefore, prolonged exposure of cells to Chit/Col scaffold did not result 884 
in cell death. Our results are in accordance with other works, where a similar tendency 885 
of MCF-7 viability was obtained after their inoculation in pure chitosan matrices for 5 886 
days of culture period (Dhiman, Ray & Panda, 2004, 2005) and in pure collagen 887 
scaffolds up to 13 days (Chen et al., 2012). Additionally, the good cytocompatibility of 888 
Chit/Col composites was also ensured by Fernandes and co-workers using MC3T3 889 
osteoblasts ((Fernandes, Resende, Tavares, Soares, CastroI & GranjeiroI, 2011) and by 890 
Tsai and collaborators with WS1 skin fibroblasts (Tsai et al., 2007). 891 
Our results were especially remarkable in the case of the 50Chit/50Col-TPP 892 
composition. Cells grew throughout these scaffolds with the fastest growth rate and 893 
doubled the cell population in the lowest time. Similar growth rates and doubling time 894 
values were obtained by Seda and co-workers, who seeded fibroblasts on pure chitosan 895 
scaffolds for 5 days (Seda Tigli, Karakecili & Gumusderelioglu, 2007). However, they 896 
detected a reduction in cell number after 3 days of culture period as well as some 897 
difficulties in achieving adequate cell growth throughout the matrix with the smallest 898 
pore size. In contrast, our scaffolds did not show any reduction in cell viability, even 899 
using the composition with the smallest pore size (80Chit/20Col-TPP-XL, 120 ± 42 900 
µm).  Consequently, the good results obtained for the screening of cell viability might 901 
indicate that the assayed chitosan/collagen scaffolds could be used for further in vitro 902 
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and in vivo studies to better evaluate which of the systems already prepared offer the 903 
best characteristics for use in TE applications.   904 
 905 
5. CONCLUSION 906 
In this study, various chitosan/collagen scaffolds have been developed and characterised 907 
in terms of some of the most important physicochemical properties to be used with TE 908 
applications. According to changes in composition and crosslinking methodology, a 909 
wide range of scaffolds with different stability, degradation and swelling properties 910 
were obtained. These scaffolds should offer great versatility for selecting the most 911 
suitable structure for specific applications in the future. However, the most significant 912 
results relate to the 20Chit/80Col composition, whose self-crosslinking phenomenon 913 
eliminates the need for using additional chemical reactants, so making the product much 914 
more biocompatible. Furthermore, the use of crosslinking reagents, especially TPP or 915 
EDAC+TPP, seems to be essential in stabilizing the scaffolds where the chitosan 916 
proportion increased. Generally, all scaffolds seeded with MCF-7 allow a gradual 917 
increase in the number of cells in 3D structures for up to 5 days. These results showed 918 
the possible application of the developed scaffolds in TE, offering the possibility of 919 
tailoring their properties according to their final biological use and the requirements of 920 
the tissue under consideration. 921 
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